Modulation of the Ca2+/Mg2+-ATPase Activity of Synaptosomal Plasma Membrane Vesicles by the Hypothalamic Hypophysary Na+/K+-ATPase Inhibitory Factor (HHIF)

M. Ricote,E. Garcia,C. Gutierrez,J. Sancho

DOI: https://doi.org/10.1007/978-3-642-72511-1_142

1994-01-01

Abstract:There is a general agreement that in essential hypertension there is a generalized alteration in membrane transport which leads to an increased peripheral resistance, decreased renal sodium excretion and plasma volume expansion (7). A circulating inhibitor of the sodium pump has been implicated in these three phenomena (3). The increased intracellular Ca2+ in vascular smooth muscle (VSM) cells is considered the final effect of the inhibitor leading to an increased contractility. It has also been speculated that this substances could be also be involved in the proliferation of VSM cells through the same mechanism. One of these factors is an endogenous compound first isolated from the hypothalamus and hypophysis, HHIF, (8) and later found to be present in other tissues although at lower concentrations (12) that has been shown to increase cell proliferation on rat mesangial cells (10). This nonpeptidic, nonlipidic Na*-pump inhibitor is different from any known cardioglycoside (12). Based in these observation and in the known fact that different ion pumping ATPases, namely Na+/K+-ATPase and Ca2+/Mg2+-ATPases, show little specificity towards inhibitors (11), we have studied the inhibition of HHIF on the Ca2+ pump of the plasma membrane of synaptosomes.